Delisting risk
Alaunos Therapeutics (TCRT)
Preclinical developer of ALN1003, an oral small molecule for obesity.
$1.69
At close+0.03 (+1.81%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions29 holders · as of Mar 31, 2026 | 4.96% | 125.9K shares | |
| Insiders6 holders · as of Aug 11, 2026 | 20.71% | 526.1K shares | |
| Otherremainder | 74.33% | 1.89M shares |
2.54M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
29 holders · 125.9K shares · 7 new positions · 13 increased · 4 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 22.6K | 0.89% | +2.8K | May 15, 2026 |
| BlackRock, Inc. | 21.4K | 0.84% | 0 | May 13, 2026 |
| Vanguard Fiduciary Trust Co | 15.5K | 0.61% | +15.5Knew | May 8, 2026 |
| Vanguard Capital Management LLC | 14.1K | 0.55% | +14.1Knew | May 15, 2026 |
| HRT Financial LP | 13.3K | 0.52% | +725 | May 14, 2026 |
| Two Sigma Investments, LP | 10.8K | 0.43% | −7.7K | May 15, 2026 |
| Citadel Advisors LLC | 10.5K | 0.41% | +10.5Knew | May 15, 2026 |
| XTX Topco Ltd | 10.2K | 0.40% | +10.2Knew | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Postma Robert Wincl. WaterMill Asset Management Corp. | 9.00% | 199.8K | 13D | Jul 1, 2025 ↗ |
| Price Adrianincl. Chris Cole, Chris Butterworth +18 more | 8.60% | 189.1K | 13D | Mar 5, 2026 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
